LPL Financial »

Revance Therapeutics shares owned by LPL Financial

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by LPL Financial from 13F filings

Historical chart of LPL Financial investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by LPL Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by LPL Financial

Quarter filed Position value Share count Share price at filing
2023-09-30 $261k 23k 11.47
2023-06-30 $602k 24k 25.31
2023-03-31 $721k 22k 32.21
2022-12-31 $259k 14k 18.46
2022-09-30 $738k 27k 26.99
2022-06-30 $184k 13k 13.79
2022-03-31 $200k 10k 19.51
2021-09-30 $539k 19k 27.86
2021-06-30 $775k 26k 29.63
2021-03-31 $824k 30k 27.94
2020-12-31 $878k 31k 28.33
2020-09-30 $1.0M 41k 25.14
2020-06-30 $969k 40k 24.41